Roche Australia's Valium recalled following evidence of tampering.
M2 PHARMA-May 31, 2017-Roche Australia's Valium recalled following evidence of tampering
(C)2017 M2 COMMUNICATIONS
The Therapeutics Goods Administration (TGA) has issued a recall notice for all 5mg tablets in 50-tablet blister packs of Valium manufactured by Roche (VTX: ROG) after the company notified the TGA that it had found evidence of tampering, the Australian Government's department reported on Wednesday.
Around 30,000 packs of the drug are distributed in Australia every month and, although the tampering isn't thought to be widespread, the company and the TGA have issued a nationwide recall.
Valium 5mg tablets contain diazepam, and are used to treat anxiety disorders, alcohol withdrawal symptoms and muscle spasms.
The TGA's statement explained that it was identified that blister pack sheets containing other medicines have been substituted into some packs of Valium 5mg tablets. These medicines may include, but may not be limited to, BTC Paracetamol Codeine tablets, BTC Rosuvastatin 10mg tablets, and Apotex-Pantoprazole 40mg and 20mg tablets.
Roche products managing director, Svend Peterson, is urging customers to return their Valium to pharmacists, who will issue a refund for any unused medicine and will arrange alternative medicine.
((Comments on this story may be sent to firstname.lastname@example.org))
|Printer friendly Cite/link Email Feedback|
|Date:||May 31, 2017|
|Previous Article:||Asana BioSciences Starts Phase 2 Evaluation of ASN002 in NHL, CLL and MF.|
|Next Article:||NLS Pharma's ADHD drug sees success in mid-stage study.|